GLP-2 TRZ – 20mg

Description

GLP-2 TRZ 20mg is a lyophilized dual incretin receptor agonist research peptide supplied as a single vial for controlled laboratory and analytical applications. Hudson Science’s formulation delivers 20mg. A higher concentration presentation than CSD’s 15mg GLP-2 TZ variant in a lyophilized format that preserves peptide structural integrity and potency across storage conditions until reconstitution. This elevated concentration is suited to research protocols requiring extended compound availability, higher dose response evaluations, or longer experimental timelines from a single vial supply.

The dual GIP and GLP-1 receptor agonism of this compound class produces a complementary mechanism of action across two distinct incretin pathways. GLP-1 receptor activation is well documented in research examining glucose dependent insulin secretion, glucagon suppression, gastric emptying delay, and appetite regulation through central nervous system satiety signaling. GIP receptor activation contributes additional insulinotropic activity alongside growing research interest in adipose tissue metabolism, bone turnover, and the synergistic incretin response produced when both pathways are activated simultaneously. This combined receptor profile has made dual incretin agonist compounds among the most actively researched peptide classes in contemporary metabolic and endocrine science.

The 20mg concentration of this Hudson Science formulation sits above the 15mg GLP-2 TZ variant in CSD’s dual incretin agonist range;  both delivering identical base compound pharmacology with concentration and manufacturer representing the primary differentiating variables. The higher unit concentration of this formulation reduces the number of vials required for extended research protocols and provides greater flexibility in dose response study design at elevated concentration points, while the lyophilized format maintains consistent peptide integrity across both presentations.

Every batch of Hudson Science’s GLP-2 TRZ is third party lab tested for concentration accuracy and purity prior to release, with COA documentation available on request. Canada Steroid Depot has supplied Canadian customers with consistently verified, accurately dosed research compounds for years, and our dual incretin agonist range covers multiple concentration options for complete research sourcing flexibility. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched alongside GLP-1 receptor agonist compounds in comparative incretin pathway and metabolic activity studies. Browse CSD’s full peptide range for complete sourcing.